Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion
Cells · 10.01.2023 · 12 (2) · 273
DOI: 10.3390/cells12020273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 10.01.2023. Verfasst von Wenbei Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 43…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Circular RNAs (circRNAs) have been found to have significant impacts on non-small cell lung cancer (NSCLC) progression through various mechanisms. However, the mechanism of circRNAs modulating tumor immune evasion in NSCLC has yet to be well-revealed. Materials and Methods: Through analyzing the expression profiles of circRNAs in NSCLC tissues, RNA FISH, pull-down assay, mass spectrometry analysis, and RIP, circCRIM1 was identified, and its interaction with IGF2BP1 was confirmed. The effects of circCRIM1 on modulating tumor immune evasion were explored via co-culture in vitro and in tumor xenograft models. Subsequently, we evaluated the regulatory effects of circCRIM1 on IGF2BP1 and screened its target genes through RNA sequencing. Finally, we explored the underlying molecular mechanisms that circCRIM1 could regulate the stability of target mRNA. Results: circCRIM1 was downregulated in NSCLC, and its expression was positively correlated with favorable prognoses. Furthermore, circCRIM1 was more stable than its linear transcript and was mainly localized in the cytoplasm. Mechanistically, circCRIM1 destabilized HLA-F mRNA via competitive binding to IGF2BP1. Importantly, the overexpression of circCRIM1 suppressed the immune evasion of NSCLC and promoted the expressions of Granzyme B, IFN-γ, and TNF-α of CD8+ T and NK cell in vitro co-culture assays and tumor xenograft models.
Conclusions
This study identifies circCRIM1 as a new tumor suppressor that inhibits tumor immune evasion through a competitive combination with IGF2BP1 to destabilize HLA-F mRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
ORCID-Profile: Wenbei Peng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, W., Ye, L., Xue, Q., Wei, X., Wang, Z., Xiang, X., Zhang, S., Zhang, P., Wang, H., & Zhou, Q. (2023). Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. Cells, 12(2), 273. https://doi.org/10.3390/cells12020273
Vancouver
Peng W, Ye L, Xue Q, Wei X, Wang Z, Xiang X, et al. Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. Cells. 2023;12(2):273. doi:10.3390/cells12020273
BibTeX
@article{Peng2023,
author = {Peng, Wenbei and Ye, Linlin and Xue, Qianqian and Wei, Xiaoshan and Wang, Zihao and Xiang, Xuan and Zhang, Siyu and Zhang, Pei and Wang, Haolei and Zhou, Qiong},
title = {Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion},
journal = {Cells},
year = {2023},
volume = {12},
number = {2},
pages = {273},
doi = {10.3390/cells12020273}
}
EUVIMED